Page Title
Drug Development Pipeline
AquADEKs
Status
To PatientsTherapeutic Approach
Nutritional-GI
AquaADEKs® is an oral antioxidant vitamin formulation specifically for people with CF.
Status
A clinical trial to assess the safety and effectiveness of AquADEKS was completed in 2008. The study showed that vitamin levels significantly increased and signs of inflammation were reduced.
A phase 2 study of AquADEKs in people with CF ages 10 and older was completed in 2015.
Sponsor
The program was sponsored by Yasoo Health, Inc and partially funded by the Cystic Fibrosis Foundation. It was conducted within the Therapeutics Development Network.
Recent Changes
12/20/2013
A reformulation and additional clinical trials are ongoing.
CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.
Learn More